Wellcome-MRC Institute of Metabolic Science Metabolic Research Laboratories
My research focuses on improving care for women and babies affected by diabetes in pregnancy, including type 1 diabetes, type 2 diabetes and gestational diabetes. Gestational diabetes is a form of diabetes which develops during pregnancy and which normally disappears after delivery of the baby. My research is supported by the Diabetes UK Harry Keen intermediate clinical fellowship and the Future leaders’ Award from the European Foundation for the Study of Diabetes in association with the Novo Nordisk Foundation.
Women with diabetes have many challenges in pregnancy. Unfortunately, mothers with diabetes and their babies experience higher rates of pregnancy complications including excessive growth (large-for-gestational age), low blood glucose levels at birth (neonatal hypoglycaemia), or need neonatal intensive care unit (NICU) admission. Exposure to diabetes antenatally also influences the long-term health of the baby and increases their risks for obesity and diabetes.